Apoptosis induction mediated through PI3-kinase/AKT/mTOR pathway using anti-ROR1 monoclonal antibody in chronic lymphocytic leukemia cells.
Amir Hossein Daneshmanesh(Karolinska University Hospital), Håkan Mellstedt(Karolinska University Hospital), Salam Khan, Ali Moshfegh(Karolinska University Hospital), Anders Österborg(Karolinska University Hospital), Mohammad Hojjat‐Farsangi(Karolinska University Hospital)
Cited by 2
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
|Journal of Clinical Oncology|1998|258
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202